RATIONALE: Bone marrow derived progenitor cells participate in the repair of injured vessels. The lungs of individuals with emphysema have reduced alveolar capillary density and increased endothelial apoptosis. We hypothesized that circulating levels of endothelial and hematopoietic progenitor cells would be reduced in this group of patients. OBJECTIVES: The goal of this study was to measure circulating levels of endothelial progenitor cells (EPCs) and hematopoietic progenitor cells (HPCs) in subjects with COPD and to determine if progenitor levels correlated with disease severity and the presence of emphysema. METHODS: Peripheral blood mononuclear cells were isolated from 61 patients with COPD and 32 control subjects. Levels of EPCs (CD45(dim) CD34+) and HPCs (CD45(+) CD34(+) VEGF-R2(+)) were quantified using multi-parameter flow cytometry. Progenitor cell function was assessed using cell culture assays. All subjects were evaluated with spirometry and CT scanning. MEASUREMENTS AND MAIN RESULTS: HPC levels were reduced in subjects with COPD compared to controls, whereas circulating EPC levels were similar between the two groups. HPC levels correlated with severity of obstruction and were lowest in subjects with severe emphysema. These associations remained after correction for factors known to affect progenitor cell levels including age, smoking status, the use of statin medications and the presence of coronary artery disease. The ability of mononuclear cells to form endothelial cell colony forming units (EC-CFU) was also reduced in subjects with COPD. CONCLUSIONS: HPC levels are reduced in subjects with COPD and correlate with emphysema phenotype and severity of obstruction. Reduction of HPCs may disrupt maintenance of the capillary endothelium, thereby contributing to the pathogenesis of COPD.
RATIONALE: Bone marrow derived progenitor cells participate in the repair of injured vessels. The lungs of individuals with emphysema have reduced alveolar capillary density and increased endothelial apoptosis. We hypothesized that circulating levels of endothelial and hematopoietic progenitor cells would be reduced in this group of patients. OBJECTIVES: The goal of this study was to measure circulating levels of endothelial progenitor cells (EPCs) and hematopoietic progenitor cells (HPCs) in subjects with COPD and to determine if progenitor levels correlated with disease severity and the presence of emphysema. METHODS: Peripheral blood mononuclear cells were isolated from 61 patients with COPD and 32 control subjects. Levels of EPCs (CD45(dim) CD34+) and HPCs (CD45(+) CD34(+) VEGF-R2(+)) were quantified using multi-parameter flow cytometry. Progenitor cell function was assessed using cell culture assays. All subjects were evaluated with spirometry and CT scanning. MEASUREMENTS AND MAIN RESULTS: HPC levels were reduced in subjects with COPD compared to controls, whereas circulating EPC levels were similar between the two groups. HPC levels correlated with severity of obstruction and were lowest in subjects with severe emphysema. These associations remained after correction for factors known to affect progenitor cell levels including age, smoking status, the use of statin medications and the presence of coronary artery disease. The ability of mononuclear cells to form endothelial cell colony forming units (EC-CFU) was also reduced in subjects with COPD. CONCLUSIONS: HPC levels are reduced in subjects with COPD and correlate with emphysema phenotype and severity of obstruction. Reduction of HPCs may disrupt maintenance of the capillary endothelium, thereby contributing to the pathogenesis of COPD.
Authors: M Peichev; A J Naiyer; D Pereira; Z Zhu; W J Lane; M Williams; M C Oz; D J Hicklin; L Witte; M A Moore; S Rafii Journal: Blood Date: 2000-02-01 Impact factor: 22.113
Authors: Shi Ju Zhang; Hao Zhang; Ying Jie Wei; Wen Jun Su; Zhong Kai Liao; Mai Hou; Jian Ye Zhou; Sheng Shou Hu Journal: Cell Res Date: 2006-06 Impact factor: 25.617
Authors: Norbert F Voelkel; Carlyne Cool; Laima Taraceviene-Stewart; Mark W Geraci; Michael Yeager; Todd Bull; Michael Kasper; Rubin M Tuder Journal: Crit Care Med Date: 2002-05 Impact factor: 7.598
Authors: Karl G Csaky; Judit Z Baffi; Gordon A Byrnes; Jeremy D Wolfe; Sara C Hilmer; Jessica Flippin; Scott W Cousins Journal: Exp Eye Res Date: 2004-06 Impact factor: 3.467
Authors: Moumita Ghosh; York E Miller; Ichiro Nakachi; Jennifer B Kwon; Anna E Barón; Alexandra E Brantley; Daniel T Merrick; Wilbur A Franklin; Robert L Keith; R William Vandivier Journal: Am J Respir Crit Care Med Date: 2018-04-01 Impact factor: 21.405
Authors: Daria Barwinska; Houssam Oueini; Christophe Poirier; Marjorie E Albrecht; Natalia V Bogatcheva; Matthew J Justice; Jacob Saliba; Kelly S Schweitzer; Hal E Broxmeyer; Keith L March; Irina Petrache Journal: Am J Physiol Lung Cell Mol Physiol Date: 2018-05-10 Impact factor: 5.464
Authors: Margaret F Doyle; Russell P Tracy; Megha A Parikh; Eric A Hoffman; Daichi Shimbo; John H M Austin; Benjamin M Smith; Katja Hueper; Jens Vogel-Claussen; Joao Lima; Antoinette Gomes; Karol Watson; Steven Kawut; R Graham Barr Journal: PLoS One Date: 2017-03-14 Impact factor: 3.240
Authors: Jéssica García-Lucio; Victor I Peinado; Lluís de Jover; Roberto Del Pozo; Isabel Blanco; Cristina Bonjoch; Núria Coll-Bonfill; Tanja Paul; Olga Tura-Ceide; Joan Albert Barberà Journal: PLoS One Date: 2018-04-19 Impact factor: 3.240
Authors: Aili L Lazaar; Lucy Yang; Rebecca L Boardley; Navin S Goyal; Jonathan Robertson; Sandra J Baldwin; David E Newby; Ian B Wilkinson; Ruth Tal-Singer; Ruth J Mayer; Joseph Cheriyan Journal: Br J Clin Pharmacol Date: 2016-01-17 Impact factor: 4.335